Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02596438 · ClinicalTrials.gov registry record

Thousand Asian American Study

A clinical trial of Hepatitis B, sponsored by University of California, Davis.

Completed
Registry status
1,076
Enrollment target
1
Study location

NCT02596438 is a study of Hepatitis B that has completed, run by University of California, Davis. The registered enrollment target is 1,076 participants, below the 1,595-participant average among 32 other Hepatitis B trials with a reported enrollment target (33% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02596438, a study of Hepatitis B, has completed, sponsored by University of California, Davis.

COMPLETED
Registry status
1,076 participants
Enrollment target
1
Study location

Study Summary

The "Thousand Asian American Study" or "TAAS" aims to test 2,000 foreign-born and children of foreign born Asian Americans residing in Sacramento county residents for HBV and (2) counsel at least 90% of those whose screening results are positive for HBV.

Conditions Studied

Interventions

  • OTHER Hepatitis B

Study Locations (1)

California

  • University of California, Davis Comprehensive Cancer Center - Sacramento

Trial Details

FieldValue
Enrollment Target 1,076 participants
Start Date 2012-10-01
Est. Completion 2017-09-30

Sponsor

University of California, Davis

657 total trials

What the Registry Record Tells You About NCT02596438

The ClinicalTrials.gov registry entry for NCT02596438 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1,076 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,595-participant average among 32 other Hepatitis B trials with a reported enrollment target (33% lower). The listed sponsor is University of California, Davis, which has 657 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Hepatitis B appearing as the primary indexed condition, and to 1 intervention - of which Hepatitis B is the first listed.

NCT02596438 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT02596438 about?

NCT02596438 is a clinical study titled "Thousand Asian American Study". The "Thousand Asian American Study" or "TAAS" aims to test 2,000 foreign-born and children of foreign born Asian Americans residing in Sacramento county residents for HBV and (2) counsel at least 90% of those whose screening results are positive for HBV.

What is the current status of trial NCT02596438?

This trial is currently completed. The enrollment target is 1,076 participants. The study started on 2012-10-01. Estimated completion is 2017-09-30.

What conditions does trial NCT02596438 study?

This clinical trial studies the following conditions: Hepatitis B.

What interventions are being tested in trial NCT02596438?

The interventions under investigation include: Hepatitis B (OTHER).

Who is sponsoring clinical trial NCT02596438?

This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02596438 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hepatitis B

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.